ArticleEpilepsia2026
Communication regarding sudden unexpected death in epilepsy to people with epilepsy and their caregivers: A scoping review from the ILAE Sudden Unexpected Death in Epilepsy Task Force.
Article in Epilepsia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Discussing sudden unexpected death in epilepsy (SUDEP) is difficult and sensitive for health care providers (HCPs), people with epilepsy (PwE), and caregivers. This scoping review examines the literature on SUDEP communication, focusing on need, timing, content, methods, facilitators, barriers, and outcomes. We performed a thematic analysis to identify themes that summarized the perceptions of the epilepsy community regarding key elements of SUDEP communication. We identified 66 articles that met inclusion criteria. These studies included more than 5300 HCPs and 40 000 PwE and caregivers. Caregivers and PwE felt that all PwE should receive SUDEP information. However, the majority of HCPs did not discuss SUDEP. The preferred source of information was an epilepsy specialist, but PwE also valued other HCPs with whom they have a trusted relationship. There was general agreement SUDEP should be discussed at diagnosis, but limited HCP time and training were barriers. Caregivers and PwE overwhelmingly wanted information about SUDEP. Greater education and training about SUDEP for HCP may facilitate communication. Fear of causing distress was the primary barrier to SUDEP communication. However, these concerns, although valid, were often exaggerated. Even in studies that found negative emotional responses to learning about SUDEP, participants regularly reported that the benefits of knowing outweighed the short-term consequences.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.